EBV-specific T cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EBV-specific T cells, covering 2012-05-22 to 2012-05-22. Get the full timeline:
Most recent: Clinical Trial Update: Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas [Phase 1]